Stock listing

Lang & Schwarz:A2JDYX Evolus, Inc. Common Stock Aktie

German listing (Lang & Schwarz) of Evolus, Inc. Common Stock · home listing NASDAQ:EOLS

Follow Evolus, Inc. Common Stock into a list and get an email when it puts out news.

Home listing price · NASDAQ:EOLS

$7.10 USD -0.47 (-6.2%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:EOLS

Evolus, Inc. Common Stock logo
Ticker
Lang & Schwarz:A2JDYX
Asset type
Stock
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Calls

Replays

  • Evolus, Inc. Common Stock (NASDAQ:EOLS) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 4:30 PM ET

    Watch Transcript

  • Evolus, Inc. Common Stock (NASDAQ:EOLS) Q1 2026 Earnings Call

    Mon, May 04, 2026 · 4:30 PM ET

    Watch Transcript

  • Evolus, Inc. Common Stock (NASDAQ:EOLS) Q4 2025 Earnings Call

    Tue, Mar 03, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration Program

Oct 14, 2026

Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes

Oct 1, 2026

Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook

Aug 5, 2026

Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand

Aug 4, 2026

Evolus to Report Second Quarter Financial Results on August 5, 2026

Jul 22, 2026

Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality

Jul 8, 2026

Evolus to Participate in The Jefferies Global Healthcare Conference

May 19, 2026

Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe

May 11, 2026

Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook

May 4, 2026

Evolus to Report First Quarter Financial Results on May 4, 2026

Apr 14, 2026

All Evolus, Inc. Common Stock news

Decks

Evolus, Inc. Common Stock on 6ix

News releases
21 in the last 12 months · 142 in all · newest Oct 14, 2026 · oldest 2019
Calls
22 calls with a replay · 22 with a transcript · latest Aug 5, 2026
Decks
16 decks · latest Aug 5, 2026

Where Evolus, Inc. Common Stock is listed

ListingExchangeCountryCurrency
NASDAQ:EOLS · Home listingNASDAQUnited StatesUSD
gettex:EVLgettexGermanyEUR
Frankfurt:EVLFrankfurtGermanyEUR
LS Exchange:A2JDYXLS ExchangeGermanyEUR
Lang & Schwarz:A2JDYX · This pageLang & SchwarzGermanyEUR
BOATS:EOLSBOATSUnited StatesUSD
Tradegate:EVLTradegateGermanyEUR
Dusseldorf:EVLDusseldorfGermanyEUR
LSE:0K16LSEUnited KingdomUSD
Munich:EVLMunichGermanyEUR
Stuttgart:EVLStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Evolus, Inc. Common Stock.